FDA Warns SGLT2 Inhibitors Could Lead to Fournier’s Gangrene
The U.S. Food and Drug Administration (FDA) recently warned consumers that a class of type 2 diabetes medications
Learn MoreLatest Articles
Tris Pharma Issues Recall on Infant Ibuprofen
Because infants are at risk for being harmed by higher concentrations of ibuprofen, Tris Pharma has voluntarily initiated
Learn More
FDA Decision Allows Generic Drug Makers to Dodge Product Liability Lawsuits
Contrary to a rule suggested by the Food and Drug Administration (FDA) in 2013 that would have allowed injured
Learn More
Childers, Schlueter, & Smith Gives back to Boys & Girls Club of Metro Atlanta
CSS firm is proud to give back to the community the for the holidays. This year, Childers, Schlueter,
Learn More
Infant Ibuprofen Recalled Nationwide Due to High Drug Concentration
New Jersey-based Tris Pharma voluntarily recalled three lots of “Infants Ibuprofen Concentrated Oral Suspension USP (NSAID) 50 mg per 1.25
Learn More